S. Ezzat

S. Ezzat, S. Samson, 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

The Endocrine System

S. Asa, S. Ezzat, Sylvia L. Asa, 2013 .

A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors.

T. Sano, S. Asa, S. Yamada, 2007, Cancer research.

AIP Mutations are not Identified in Patients with Sporadic Pituitary Adenomas

S. Asa, S. Ezzat, S. Serra, 2007, Endocrine pathology.

Mechanisms of Disease: the pathogenesis of pituitary tumors

S. Asa, S. Ezzat, 2006, Nature Clinical Practice Endocrinology &Metabolism.

Current views on pathogenesis of pituitary tumors

S. Asa, S. Ezzat, 2004 .

A detailed spatial analysis on contrasting cancer incidence patterns in thyroid and lung cancer in Toronto women

S. Ezzat, A. Sawka, P. Brown, 2016, BMC Public Health.

Myostatin is a skeletal muscle target of growth hormone anabolic action.

W. Liu, S. Asa, S. Ezzat, 2003, The Journal of clinical endocrinology and metabolism.

Endocrine Gland Imaging

S. Ezzat, S. Ghai, Katerina Mastrocostas, 2019, Medical Imaging for Health Professionals.

Epigenetics of Pituitary Cell Growth and Survival

T. Tateno, S. Ezzat, Karen Gómez-Hernández, 2021, Cellular Endocrinology in Health and Disease.

Epigenetics of pituitary tumors: Pathogenetic and therapeutic implications

S. Asa, S. Ezzat, Sonia Cheng, 2017, Molecular and Cellular Endocrinology.

Epigenetics of Pituitary Cell Growth and Survival

T. Tateno, S. Ezzat, Karen Gómez-Hernández, 2021, Cellular Endocrinology in Health and Disease.

Genomic Approaches to Problems in Pituitary Neoplasia

S. Asa, S. Ezzat, 2014, Endocrine Pathology.

Chromatin remodeling and histone modifications in pituitary tumors

T. Tateno, S. Asa, S. Ezzat, 2010, Molecular and Cellular Endocrinology.

Fibroblast Growth Factor 2 and Estrogen Control the Balance of Histone 3 Modifications TargetingMAGE-A 3 in Pituitary Neoplasia

S. Asa, S. Ezzat, Xuegong Zhu, 2008 .

Fibroblast Growth Factor 2 and Estrogen Control the Balance of Histone 3 Modifications Targeting MAGE-A3 in Pituitary Neoplasia

S. Asa, S. Ezzat, Xuegong Zhu, 2008, Clinical Cancer Research.

High-throughput drug library screening identifies colchicine as a thyroid cancer inhibitor

A. Pasculescu, S. Asa, S. Ezzat, 2016, Oncotarget.

Molecular Determinants of Pituitary Cytodifferentiation

S. Asa, S. Ezzat, 1999, Pituitary.

Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis.

A. Gafni, S. Straus, S. Ezzat, 2007, Thyroid : official journal of the American Thyroid Association.

Acromegaly: Re-thinking the cancer risk

S. Ezzat, S. Loeper, 2008, Reviews in Endocrine and Metabolic Disorders.

C. Cheung, S. Asa, S. Ezzat, 2022 .

ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?

S. Asa, S. Ezzat, J. Freeman, 1996, The Journal of clinical endocrinology and metabolism.

IGF‐I and testosterone levels as predictors of bone mineral density in healthy, community‐dwelling men

S. Ezzat, J. Khosravi, D. Hanley, 2004, Clinical endocrinology.

Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus.

S. Asa, S. Ezzat, H. Kennecke, 2016, Cancer treatment reviews.

I. G. Fantus, S. Ezzat, D. Page, 2004, Breast Cancer Research and Treatment.

The Impact of Thyroid Cancer and Post-Surgical Radioactive Iodine Treatment on the Lives of Thyroid Cancer Survivors: A Qualitative Study

A. Gafni, S. Straus, S. Ezzat, 2009, PloS one.

Thyroid cancer is the most common malignancy arising from hormone-producing glands. Preface.

S. Asa, S. Ezzat, 2008, Endocrinology and metabolism clinics of North America.

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer: update to study protocol with follow-up extension

A. Gafni, S. Straus, S. Ezzat, 2015, Trials.

Protocol for the examination of specimens from patients with pheochromocytomas and extra-adrenal paragangliomas.

A. Tischler, S. Asa, S. Ezzat, 2014, Archives of pathology & laboratory medicine.

Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma

S. Ezzat, J. Sexton, M. Abdel-Rahman, 2010, Familial Cancer.

Current management of papillary thyroid microcarcinoma in Canada

S. Ezzat, D. Goldstein, J. Freeman, 2014, Journal of Otolaryngology - Head & Neck Surgery.

Exploring the Life Impact of Treated Low-Risk Thyroid Cancer.

S. Ezzat, D. Goldstein, A. Sawka, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Lessons learned from thyroglobulin concentrations after total thyroidectomy and radioactive iodine ablation for differentiated thyroid cancer.

S. Ezzat, Karen Gómez-Hernández, 2015, Clinical biochemistry.

The rationale of patients with early-stage papillary thyroid cancer for accepting or rejecting radioactive iodine remnant ablation.

A. Gafni, S. Asa, S. Ezzat, 2013, Thyroid : official journal of the American Thyroid Association.

Dietary iodine restriction in preparation for radioactive iodine treatment or scanning in well-differentiated thyroid cancer: a systematic review.

S. Ezzat, R. Tsang, J. Brierley, 2010, Thyroid : official journal of the American Thyroid Association.

CtBP1 interacts with Ikaros and modulates pituitary tumor cell survival and response to hypoxia.

S. Asa, S. Ezzat, Caimei Yang, 2012, Molecular endocrinology.

Acromegaly: Clinical and Biochemical Features in 500 Patients

A. Harris, D. Redelmeier, S. Ezzat, 1994, Medicine.

Papillary Thyroid Cancers with Focal Tall Cell Change are as Aggressive as Tall Cell Variants and Should Not be Considered as Low-Risk Disease

S. Asa, S. Ezzat, R. Tsang, 2019, Annals of Surgical Oncology.

1alpha,25-Dihydroxyvitamin D3 targets PTEN-dependent fibronectin expression to restore thyroid cancer cell adhesiveness.

W. Liu, S. Asa, S. Ezzat, 2005, Molecular endocrinology.

Controversies in papillary microcarcinoma of the thyroid

S. Asa, S. Ezzat, M. Piersanti, 2003, Endocrine pathology.

Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.

S. Asa, S. Ezzat, D. Goldstein, 2019, Current oncology.

A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial

Lisa I. Wang, S. Asa, S. Ezzat, 2019, British Journal of Cancer.

Oncogene profile of papillary thyroid carcinoma.

S. Asa, S. Ezzat, J. Freeman, 1999, Surgery.

Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms

M. Papotti, O. Basturk, S. Asa, 2022, Endocrine Pathology.

Rationale and evidence for sunitinib in the treatment of malignant paraganglioma/pheochromocytoma.

A. Evans, S. Asa, S. Ezzat, 2009, The Journal of clinical endocrinology and metabolism.

The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly.

G. Booth, S. Asa, K. Kovacs, 2005, The Journal of clinical endocrinology and metabolism.

Symptom burden in adults with thyroid cancer

S. Ezzat, R. Tsang, J. Brierley, 2018, Psycho-oncology.

ret/PTC-1, -2, and -3 oncogene rearrangements in human thyroid carcinomas: implications for metastatic potential?

S. Asa, S. Ezzat, J. Freeman, 1996, The Journal of clinical endocrinology and metabolism.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND TREATMENT OF ACROMEGALY AACE Acromegaly Guidelines Task Force Chairman

S. Ezzat, M. Vance, D. Cook, 2004 .

Pharmacological approach to the treatment of acromegaly.

S. Ezzat, 2004, Neurosurgical focus.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND TREATMENT OF ACROMEGALY

S. Ezzat, M. Vance, D. Cook, 2004 .

The Management of Neuro-Endocrine Neoplasms

S. Ezzat, A. Akirov, L. Amer, 2020 .

Treatment Options for Pancreatic Neuroendocrine Tumors

S. Asa, S. Ezzat, A. Akirov, 2019, Cancers.

An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors

S. Asa, S. Ezzat, O. Mete, 2019, Endocrine Pathology.

Malignant pheochromocytoma secreting vasoactive intestinal peptide and response to sunitinib: a case report and literature review.

S. Asa, S. Ezzat, A. Joshua, 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism

S. Asa, S. Ezzat, 2021, Journal of clinical medicine.

Pathology of pituitary growth hormone excess

S. Asa, S. Ezzat, 2021 .

The Clinicopathological Spectrum of Acromegaly

S. Asa, S. Ezzat, I. Shimon, 2019, Journal of clinical medicine.

Pituitary acromegaly: not one disease.

W. Kucharczyk, S. Asa, S. Ezzat, 2017, Endocrine-related cancer.

Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways.

Wei Liu, I. G. Fantus, S. Asa, 2002, The American journal of pathology.

The Role of Diabetes in Acromegaly Associated Neoplasia

S. Ezzat, K. Gomez, C. Chik, 2015, PloS one.

Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation.

J. Wrana, S. Ezzat, A. Datti, 2009, Cancer research.

Pancreatic endocrine pathology in von hippel-lindau disease: An expanding spectrum of lesions

S. Asa, S. Ezzat, R. Chetty, 2004, Endocrine pathology.

The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression and response to mTOR inhibition therapy.

Manal M. Hassan, S. Asa, S. Ezzat, 2012, Cancer research.

Metabolic Glucose Status and Pituitary Pathology Portend Therapeutic Outcomes in Acromegaly

S. Ezzat, Sonia Cheng, O. Serri, 2013, PloS one.

Clinical case seminar: lymphocytic hypophysitis: clinicopathological findings.

S. Asa, K. Kovacs, S. Ezzat, 1995, The Journal of clinical endocrinology and metabolism.

Pituitary Endocrine Function Testing

S. Ezzat, 2013 .

Response: Letter to Editor "A prospective mixed-methods study of decision-making on surgery or active surveillance for low risk papillary thyroid cancer".

A. Gafni, S. Ezzat, D. Goldstein, 2020, Thyroid : official journal of the American Thyroid Association.

Management of Small Bowel Neuroendocrine Tumors

S. Ezzat, A. Akirov, V. Larouche, 2019, Cancers.

Osteopontin stimulates invasion of NCI‐h295 cells but is not associated with survival in adrenocortical carcinoma

P. Adam, Wei Liu, S. Asa, 2009, The Journal of pathology.

Growth factors and their receptors in the genesis and treatment of thyroid cancer.

S. Ezzat, 2004, Cancer treatment and research.

The endogenous fibroblast growth factor-2 antisense gene product regulates pituitary cell growth and hormone production.

S. Asa, S. Ezzat, P. Murphy, 2001, Molecular endocrinology.

Basic fibroblast growth factor expression by two prolactin and thyrotropin-producing pituitary adenomas

S. Asa, K. Kovacs, S. Ezzat, 1995, Endocrine pathology.

Vitamin D and Its Analog EB1089 Induce p27 Accumulation and Diminish Association of p27 with Skp2 Independent of PTEN in Pituitary Corticotroph Cells

W. Liu, S. Asa, S. Ezzat, 2002, Brain pathology.

Endoscopic Endonasal Pituitary Surgery For Nonfunctioning Pituitary Adenomas: Long-Term Outcomes and Management of Recurrent Tumors.

S. Asa, S. Ezzat, J. Almeida, 2020, World neurosurgery.

Evidence for growth hormone (GH) autoregulation in pituitary somatotrophs in GH antagonist-transgenic mice and GH receptor-deficient mice.

S. Asa, S. Ezzat, J. Kopchick, 2000, The American journal of pathology.

Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-releasing hormone-producing bronchial carcinoid.

S. Asa, K. Kovacs, S. Ezzat, 1994, The Journal of clinical endocrinology and metabolism.

PREDICTIVE MARKERS FOR POSTSURGICAL MEDICAL MANAGEMENT OF ACROMEGALY: A SYSTEMATIC REVIEW AND CONSENSUS TREATMENT GUIDELINE.

H. Lochnan, S. Ezzat, S. Van Uum, 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Vitamin D inhibits CEACAM1 to promote insulin/IGF-I receptor signaling without compromising anti-proliferative action

W. Liu, S. Asa, S. Ezzat, 2011, Laboratory Investigation.

Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness.

S. Asa, S. Ezzat, V. K. LeRiche, 1996, The Journal of clinical endocrinology and metabolism.

The spectrum and significance of primary hypophysitis.

C. Cheung, S. Asa, S. Ezzat, 2001, The Journal of clinical endocrinology and metabolism.

More about hyperprolactinemia

S. Ezzat, O. Serri, 2004 .

A Canadian multi-centre, open-label long-term study of Pegvisomant treatment in refractory acromegaly.

S. Ezzat, E. Ur, C. Chik, 2009, Clinical and investigative medicine. Medecine clinique et experimentale.

Ventilation threshold as a measure of impaired physical performance in adults with growth hormone excess

S. Ezzat, L. Woodhouse, Scott Thomas, 2002, Clinical endocrinology.

Pituitary tumor pathogenesis--the hunt for novel candidate genes continues.

S. Ezzat, 2003, The Journal of clinical endocrinology and metabolism.

Longitudinal assessment of economic burden and clinical outcomes in acromegaly.

S. Ezzat, L. Wilson, J. Shin, 2001, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Pancreatic Neuroendocrine Tumors Producing GHRH, GH, Ghrelin, PTH, or PTHrP

S. Asa, S. Ezzat, K. Duan, 2015 .

SCP2 variant is associated with alterations in lipid metabolism, brainstem neurodegeneration, and testicular defects

V. Papadopoulos, S. Ezzat, Melanie Galano, 2022, Human genomics.

Risk of Adverse Cardiovascular Outcomes in Differentiated Thyroid Cancer Survivors: A Systematic Review and Meta-analysis.

S. Ezzat, A. Sawka, E. Uleryk, 2022, Thyroid : official journal of the American Thyroid Association.

Complex Endocrinopathies in MEN-1: Diagnostic Dilemmas in Endocrine Oncology

S. Asa, S. Ezzat, G. Rambaldini, 2007, Endocrine pathology.

The retrotransposon gag domain containing protein Rgag4 is an Ikaros target in the pituitary

S. Asa, S. Ezzat, Zhongyi Shen, 2017, Molecular and Cellular Endocrinology.

Membrane-anchored expression of transforming growth factor-alpha in human pituitary adenoma cells.

S. Asa, S. Ezzat, H. Smyth, 1995, The Journal of clinical endocrinology and metabolism.

Vitamin D3 administration induces nuclear p27 accumulation, restores differentiation, and reduces tumor burden in a mouse model of metastatic follicular thyroid cancer.

Wei Liu, S. Asa, S. Ezzat, 2004, Endocrinology.

The c‐erbB‐2/neu proto‐oncogene in human pituitary tumours

S. Asa, S. Ezzat, H. Smyth, 1997, Clinical endocrinology.

Contributors

Lily Q. Dong, Armando R. Tovar, S. Sealfon, 1988, International Journal of Technology Assessment in Health Care.

Exercise training benefits growth hormone (GH)-deficient adults in the absence or presence of GH treatment.

S. Ezzat, Scott Thomas, J. Esposito, 2003, The Journal of clinical endocrinology and metabolism.

Altered expression of fibroblast growth factor receptors in human pituitary adenomas.

S. Asa, S. Ezzat, S. Abbass, 1997, The Journal of clinical endocrinology and metabolism.

Emerging trends in the diagnosis and treatment of acromegaly in Canada

S. Ezzat, S. Imran, E. Ur, 2013, Clinical endocrinology.

Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to up-regulate a survival signal in pituitary cells.

S. Asa, S. Ezzat, Xuegong Zhu, 2006, Molecular endocrinology.

The Insulin Resistance Grb14 Adaptor Protein Promotes Thyroid Cancer Ret Signaling and Progression

S. Asa, S. Ezzat, Sonia Cheng, 2011, Oncogene.

A large and aggressive fibromatosis in the axilla: a rare case report and review of the literature

S. Ezzat, H. Xing, Le Zhang, 2018, OncoTargets and therapy.

Distinct clonal composition of primary and metastatic adrencorticotrophic hormone‐producing pituitary carcinoma

G. Booth, S. Asa, S. Ezzat, 2001, Clinical endocrinology.

Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma.

S. Asa, S. Ezzat, M. Khoo, 2002, The Journal of clinical endocrinology and metabolism.

Management of Lesions of the Pituitary Stalk and Hypothalamus

S. Asa, S. Ezzat, L. Lipscombe, 2003 .

Clinicopathological variations in cushing’s syndrome

G. Booth, S. Asa, K. Kovacs, 1999, Endocrine pathology.

[13C]NMR studies of the effect of the somatostatin analogue octreotide on hepatic glycogenesis and glycogenolysis

A. Harris, C. Pahl-Wostl, M. Rudin, 1994, Peptides.

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY DISEASE STATE CLINICAL REVIEW: CLINICAL RELEVANCE OF MACROPROLACTIN IN THE ABSENCE OR PRESENCE OF TRUE HYPERPROLACTINEMIA.

S. Ezzat, S. Samson, A. Hamrahian, 2015, Endocrine Practice.

Octreotide treatment of acromegaly. A randomized, multicenter study.

W. Young, S. Ezzat, M. Vance, 1992, Annals of internal medicine.

Pseudopheochromocytoma of pregnancy.

S. Asa, S. Ezzat, B. Shah, 2003, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

An essential role for the hematopoietic transcription factor Ikaros in hypothalamic–pituitary-mediated somatic growth

C. Ackerley, S. Asa, S. Ezzat, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Cell-specific expression of estrogen receptor in the human pituitary and its adenomas.

S. Asa, S. Ezzat, M. Zafar, 1995, The Journal of clinical endocrinology and metabolism.

A primer on the genetics of medullary thyroid cancer.

S. Ezzat, M. Krzyzanowska, A. Akirov, 2019, Current oncology.

Short-term safety and efficacy of human GH replacement therapy in 595 adults with GH deficiency: a comparison of two dosage algorithms.

S. Ezzat, P. Sönksen, A. Luger, 2002, The Journal of clinical endocrinology and metabolism.

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly--2011 update: executive summary.

S. Ezzat, J. Atkinson, D. Cook, 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Is granulomatous thyroiditis a complication of breast implants?

S. Asa, S. Ezzat, Ally P. H. Prebtani, 2002, Endocrine pathology.

The zinc finger Ikaros transcription factor regulates pituitary growth hormone and prolactin gene expression through distinct effects on chromatin accessibility.

S. Asa, S. Ezzat, Shunjiang Yu, 2005, Molecular endocrinology.

Case Report: Adrenal LH/hCG Receptor Overexpression and Gene Amplification Causing Pregnancy-Induced Cushing’s Syndrome

S. Asa, S. Ezzat, Y. Erbil, 2009, Endocrine pathology.

Liver Transplantation in a Young Patient with Severe and Refractory Carcinoid Syndrome

S. Asa, S. Ezzat, I. McGilvray, 2018, AACE Clinical Case Reports.

Epigenetic dysregulation in thyroid neoplasia.

S. Asa, S. Ezzat, T. Kondo, 2008, Endocrinology and metabolism clinics of North America.

Dexamethasone increases ubiquitin transcription through an SP-1 dependent mechanism in multiple myeloma cells.

S. Ezzat, X. Mao, R. Hurren, 2008, Leukemia research.

Mutations of the MEN1 tumor suppressor gene in pituitary tumors.

F. Collins, L. Liotta, M. Emmert-Buck, 1997, Cancer research.

Prolactin-producing pituitary adenoma in a male-to-female transsexual patient with protracted estrogen administration. A morphologic study.

K. Kovacs, S. Ezzat, L. Ştefăneanu, 1994, Archives of pathology & laboratory medicine.

Cushing’s Syndrome from an ectopic pituitary adenoma with peliosis: A histological, immunohistochemical, and ultrastructural study and review of the literature

K. Kovacs, S. Ezzat, É. Horváth, 1997, Endocrine pathology.

Establishment and Characterization of a Human Neuroendocrine Tumor Xenograft

S. Asa, S. Ezzat, T. Stockley, 2016, Endocrine Pathology.

Hypothalamic hormone-producing tumors.

S. Asa, S. Ezzat, 2021, Handbook of clinical neurology.

Hypothalamic Vasopressin-Producing Tumors: Often Inappropriate Diuresis But Occasionally Cushing Disease

S. Asa, S. Ezzat, L. Thompson, 2019, The American journal of surgical pathology.

From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal.

P. Chanson, S. Asa, S. Ezzat, 2017, Endocrine-related cancer.

Brain metastasis from medullary thyroid carcinoma

T. Kiehl, S. Asa, S. Ezzat, 2010, BMJ Case Reports.

Circulating and synovial levels of IGF‐I, cytokines, physical function and anthropometry differ in women awaiting total knee arthroplasty when compared to men

S. Ezzat, L. Woodhouse, Scott Thomas, 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

The cytogenesis and pathogenesis of pituitary adenomas.

S. Asa, S. Ezzat, S L Asa, 1998, Endocrine reviews.

ENDOCRINE COMPLICATIONS IN PATIENTS WITH GVHD.

S. Ezzat, J. Lipton, A. Sawka, 2019, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Tools for Enhancement and Quality Improvement of Peer Assessment and Clinical Care in Endocrinology and Metabolism.

R. Hegele, S. Ezzat, S. Van Uum, 2017, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Pathogenetic mechanisms in thyroid follicular-cell neoplasia

S. Asa, S. Ezzat, T. Kondo, 2006, Nature Reviews Cancer.

Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function.

W. Liu, J. Dennis, P. Boutros, 2008, Cancer research.

Expression of steroidogenic factor-1 (SF-1) mRNA and protein in the human placenta.

S. Asa, S. Ezzat, A. Bamberger, 1996, Molecular human reproduction.

A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors

A. Gafni, S. Straus, S. Ezzat, 2008, Clinical endocrinology.

Immunohistochemical Diagnosis of Papillary Thyroid Carcinoma

C. Cheung, S. Asa, S. Ezzat, 2001, Modern Pathology.

FGFR2 isoforms support epithelial-stromal interactions in thyroid cancer progression.

Wei Liu, S. Asa, S. Ezzat, 2012, Cancer research.

AACE / ACE Disease State Clinical Review

S. Ezzat, S. Samson, A. Hamrahian, 2015 .

Diagnosis and management of hyperprolactinemia.

S. Ezzat, E. Ur, C. Chik, 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

A systematic review of randomized controlled trials for management of persistent post-treatment fatigue in thyroid cancer survivors.

S. Ezzat, J. Jones, A. Sawka, 2015, Thyroid : official journal of the American Thyroid Association.

Persistent posttreatment fatigue in thyroid cancer survivors: a scoping review.

S. Ezzat, J. Jones, C. Kelly, 2014, Endocrinology and metabolism clinics of North America.

Basis for physician recommendations for adjuvant radioiodine therapy in early-stage thyroid carcinoma: principal findings of the Canadian-American thyroid cancer survey.

A. Gafni, S. Straus, S. Ezzat, 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Unmet Information Needs of Low-Risk Thyroid Cancer Survivors.

S. Ezzat, R. Tsang, J. Brierley, 2016, Thyroid : official journal of the American Thyroid Association.

ACTH-Dependent Cushing Syndrome in Metastatic Acinic Cell Carcinoma: A Poor Prognostic Factor

S. Ezzat, S. Van Uum, S. D. MacNeil, 2023, Annals of Internal Medicine: Clinical Cases.

Metastasis of urothelial sarcomatoid carcinoma to a toxic multinodular goiter

S. Ezzat, G. Papi, S. Corrado, 2005, Endocrine pathology.

Growth hormone treatment improves peripheral muscle oxygen extraction-utilization during exercise in patients with human immunodeficiency virus-associated wasting: a randomized controlled trial.

S. Ezzat, Scott Thomas, J. Esposito, 2004, The Journal of clinical endocrinology and metabolism.

The breast cancer susceptibility FGFR2 provides an alternate mode of HER2 activation.

S. Asa, S. Ezzat, S. Serra, 2015, Oncogene.

Metastatic thyroid carcinoma to the gastric body.

S. Asa, S. Ezzat, J. Brierley, 2014, The Journal of clinical endocrinology and metabolism.

Carney complex with adrenal cortical carcinoma.

S. Asa, S. Ezzat, J. Wasserman, 2012, The Journal of clinical endocrinology and metabolism.

Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification

S. Asa, S. Yamada, S. Ezzat, 2021, Modern Pathology.

Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?

S. Asa, S. Ezzat, O. Mete, 2021, Endocrine Pathology.

FGFR4 polymorphic alleles modulate mitochondrial respiration: A novel target for somatostatin analog action in pituitary tumors

S. Asa, S. Ezzat, M. Pintilie, 2016, Oncotarget.

Gonadotrope Tumors.

S. Asa, S. Ezzat, 2016, Progress in molecular biology and translational science.

FGFR4 polymorphic variants modulate phenotypic features of Cushing disease.

T. Tateno, S. Asa, S. Yamada, 2014, Molecular endocrinology.

The FGFR4-G388R Polymorphism Promotes Mitochondrial STAT3 Serine Phosphorylation to Facilitate Pituitary Growth Hormone Cell Tumorigenesis

T. Tateno, S. Asa, S. Ezzat, 2011, PLoS genetics.

Pituitary Tumors, Molecular Pathogenesis

S. Ezzat, 2004 .

The pathogenesis of pituitary tumours

S. Asa, S. Ezzat, 2002, Nature Reviews Cancer.

Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/N-cadherin signaling to diminish cell adhesiveness: a mechanism underlying pituitary neoplasia.

S. Asa, S. Ezzat, Lei Zheng, 2004, Molecular endocrinology.

Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis.

Gillian E. Wu, S. Asa, S. Ezzat, 2002, The Journal of clinical investigation.

Dopaminergic Resistant Prolactinomas in the Peripubertal Population

S. Ezzat, J. Hamilton, C. Huang, 2006, Journal of pediatric endocrinology & metabolism : JPEM.

Clinical Implications of Accurate Subtyping of Pituitary Adenomas: Perspectives from the Treating Physician.

S. Asa, S. Ezzat, Karen Gómez-Hernández, 2015, Turk patoloji dergisi.

The emerging role of the Ikaros stem cell factor in the neuroendocrine system.

S. Asa, S. Ezzat, 2008, Journal of molecular endocrinology.

Ikaros modulates cholesterol uptake: a link between tumor suppression and differentiation.

S. Asa, S. Ezzat, S. Loeper, 2008, Cancer research.

Ikaros integrates endocrine and immune system development.

Shereen Ezzat, S. Asa, S. Ezzat, 2005, The Journal of clinical investigation.

Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoter.

S. Asa, S. Ezzat, Shunjiang Yu, 2003, The American journal of pathology.

Chromatin remodeling: the interface between extrinsic cues and the genetic code?

S. Ezzat, 2008, Clinical and investigative medicine. Medecine clinique et experimentale.

Mice lacking the transcription factor Ikaros display behavioral alterations of an anti-depressive phenotype

T. Kiehl, S. Asa, S. Ezzat, 2008, Experimental Neurology.

Ikaros is regulated through multiple histone modifications and deoxyribonucleic acid methylation in the pituitary.

S. Asa, S. Ezzat, Xuegong Zhu, 2007, Molecular endocrinology.

Tyrosine kinase receptors as molecular targets In pheochromocytomas and paragangliomas

Wei Liu, S. Asa, S. Ezzat, 2014, Modern Pathology.

Growth Factors , Cytokines , Cell Cycle Molecules Loss of Heterozygosity and DNA Methylation Affect Germline Fibroblast Growth Factor Receptor 4 Polymorphism to Direct Allelic Selection in Breast Cancer

S. Asa, S. Ezzat, Xuegong Zhu, 2010 .

The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas.

T. Tateno, S. Asa, S. Ezzat, 2014, Endocrine-related cancer.

A chemical biology screen identifies glucocorticoids that regulate c-maf expression by increasing its proteasomal degradation through up-regulation of ubiquitin.

S. Corey, S. Trudel, S. Ezzat, 2007, Blood.

upregulation of ubiquitin expression by increasing its proteasomal degradation through A chemical biology screen identifies glucocorticoids that regulate

S. Corey, S. Trudel, S. Ezzat, 2007 .

The epigenetic landscape of differentiated thyroid cancer

S. Asa, S. Ezzat, 2017, Molecular and Cellular Endocrinology.

MALIGNANT OVARIAN STEROID CELL TUMOR CAUSING SEVERE HYPERANDROGENISM: CASE REPORT AND REVIEW OF THE LITERATURE

B. Clarke, S. Asa, S. Ezzat, 2017 .

Genetic and epigenetic mechanisms down-regulate FGF receptor 2 to induce melanoma-associated antigen A in breast cancer.

S. Asa, S. Ezzat, Xuegong Zhu, 2010, The American journal of pathology.

Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancer.

S. Asa, S. Ezzat, Xuegong Zhu, 2009, Molecular endocrinology.

A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial

S. Asa, S. Ezzat, A. Hansen, 2019, British Journal of Cancer.

American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update.

S. Ezzat, J. Atkinson, D. Cook, 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

AACE Acromegaly Task Force Chair

S. Ezzat, J. Atkinson, D. Cook, 2011 .

The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults.

S. Ezzat, L. Woodhouse, S. Shalet, 2006, Endocrine reviews.

Clonality of thyroid nodules in sporadic goiter.

S. Asa, S. Ezzat, V. Livolsi, 1995, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Cystic lesions of the pituitary: clinicopathological features distinguishing craniopharyngioma, Rathke's cleft cyst, and arachnoid cyst.

S. Asa, S. Ezzat, L. Woodhouse, 1999, The Journal of clinical endocrinology and metabolism.

Molecular profiling confirms historical immunohistochemistry in acromegaly.

S. Asa, S. Ezzat, 2020, Endocrine-related cancer.

Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas

W. Kucharczyk, S. Asa, S. Ezzat, 2016, Modern Pathology.

Targeting N-cadherin through fibroblast growth factor receptor-4: distinct pathogenetic and therapeutic implications.

S. Asa, S. Ezzat, D. Winer, 2006, Molecular endocrinology.

The molecular pathogenetic role of cell adhesion in endocrine neoplasia

S. Asa, S. Ezzat, Sylvia L. Asa, 2005, Journal of Clinical Pathology.

The Role of Hormones, Growth Factors and Their Receptors in Pituitary Tumorigenesis

S. Ezzat, 2001, Brain pathology.

Co‐occurrence of breast cancer and neuroendocrine tumours: New genetic insights beyond Multiple Endocrine Neoplasia syndromes

S. Ezzat, R. Kim, A. Akirov, 2019, Endocrinology, diabetes & metabolism.

Molecular Predictors of Clinical Behavior in Pituitary Adenohypophysial Tumors

S. Asa, S. Ezzat, 2019, Pituitary Disorders of Childhood.

Aggressive Pituitary Tumors or Localized Pituitary Carcinomas: Defining Pituitary Tumors

S. Asa, S. Ezzat, 2016, Expert review of endocrinology & metabolism.

Biomarkers of aggressive pituitary adenomas.

S. Asa, S. Ezzat, O. Mete, 2012, Journal of molecular endocrinology.

Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in nonfunctioning pituitary adenomas: a high throughput TMA, immunohistochemical study.

Shereen Ezzat, Gerardo Guinto, S. Asa, 2012, The Journal of clinical endocrinology and metabolism.

Genetics and proteomics of pituitary tumors

S. Asa, S. Ezzat, 2005, Endocrine.

Primary mediastinal paraganglioma associated with a familial variant in the succinate dehydrogenase B subunit gene

S. Ezzat, R. Kim, N. Samuel, 2018, Journal of surgical oncology.

Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors

Julian R. E. Davis, H. Randeva, R. Eeles, 2020, The Journal of clinical endocrinology and metabolism.

The MEN-1 gene is rarely down-regulated in pituitary adenomas.

S. Asa, S. Ezzat, K. Somers, 1998, The Journal of clinical endocrinology and metabolism.

Progression of subacute (de Quervain's) thyroiditis into Hashimoto's thyroiditis.

S. Ezzat, G. Papi, 2004, Thyroid : official journal of the American Thyroid Association.

A High-Throughput Proteomic Approach Provides Distinct Signatures for Thyroid Cancer Behavior

S. Asa, S. Ezzat, S. Serra, 2011, Clinical Cancer Research.

The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph.

S. Asa, S. Ezzat, A. Bamberger, 1996, The Journal of clinical endocrinology and metabolism.

Molecular basis of pituitary development and cytogenesis.

S. Asa, S. Ezzat, 2004, Frontiers of hormone research.

Pathology, pathophysiology, and treatment strategies of endocrine disorders and their cardiac complications.

S. Ezzat, J. Butany, A. Luk, 2013, Seminars in diagnostic pathology.

The Diagnosis and Clinical Significance of Paragangliomas in Unusual Locations

S. Asa, S. Ezzat, O. Mete, 2018, Journal of clinical medicine.

Cyclin D1 protein expression predicts metastatic behavior in thyroid papillary microcarcinomas but is not associated with gene amplification.

S. Asa, S. Ezzat, M. Khoo, 2002, The Journal of clinical endocrinology and metabolism.

Pituitary Adenomas Presenting as Sinonasal or Nasopharyngeal Masses: A Case Series Illustrating Potential Diagnostic Pitfalls

S. Asa, S. Ezzat, M. Hyrcza, 2017, The American journal of surgical pathology.

Cytoplasmic staining of erbB‐2 but not mRNA levels correlates with differentiation in human thyroid neoplasia

S. Asa, S. Ezzat, J. Freeman, 1998, Clinical endocrinology.

Genetic events in the evolution of thyroid cancer.

Camilla M. A. Carroll, S. Asa, S. Ezzat, 2002, The Journal of otolaryngology.

Familial pheochromocytoma and renal cell carcinoma syndrome: TMEM127 as a novel candidate gene for the association

B. Dickson, S. Asa, S. Ezzat, 2015, Virchows Archiv.

Functional Cardiac Paraganglioma Associated with a Rare SDHC Mutation

S. Asa, S. Ezzat, S. Keshavjee, 2014, Endocrine Pathology.

Fibroblast growth factor receptors as molecular targets in thyroid carcinoma.

Wei Liu, S. Asa, S. Ezzat, 2005, Endocrinology.

The Clinicopathological Spectrum of Parathyroid Carcinoma

S. Asa, S. Ezzat, R. Jang, 2019, Front. Endocrinol..

Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cells.

S. Asa, S. Ezzat, Xuegong Zhu, 2007, The American journal of pathology.

Overt immune dysfunction after Cushing's syndrome remission: a consecutive case series and review of the literature.

S. Ezzat, Filipe da Mota, C. Murray, 2011, The Journal of clinical endocrinology and metabolism.

Deoxyribonucleic acid methyltransferase 3B promotes epigenetic silencing through histone 3 chromatin modifications in pituitary cells.

S. Asa, S. Ezzat, X. Mao, 2008, The Journal of clinical endocrinology and metabolism.

DNA Methyl-Transferase 3B Promotes Epigenetic Silencing Through Histone 3 Chromatin Modifications in Pituitary Cells

S. Asa, S. Ezzat, X. Mao, 2008 .

Granulomatous hypophysitis with psammoma bodies: A diagnostic dilemma

S. Asa, K. Kovacs, S. Ezzat, 2004, Endocrine pathology.

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer - a randomized controlled trial

A. Gafni, S. Straus, S. Ezzat, 2010, Trials.

Endoscopic Treatment of Rathke’s Cleft Cysts: The Case for Simple Fenestration

S. Ezzat, G. Zadeh, F. Gentili, 2022, Brain sciences.

GNAq Mutations are Not Identified in Papillary Thyroid Carcinomas and Hyperfunctioning Thyroid Nodules

S. Asa, S. Ezzat, M. Guo, 2010, Endocrine pathology.

Autoimmune Hypophysitis

S. Ezzat, R. Josse, 1997, Trends in Endocrinology & Metabolism.

Endoscopic treatment of sellar arachnoid cysts via a simple cyst-opening technique: Long-term outcomes from a single center.

S. Ezzat, G. Zadeh, A. Vescan, 2022, World neurosurgery.

Epigenetically controlled fibroblast growth factor receptor 2 signaling imposes on the RAS/BRAF/mitogen-activated protein kinase pathway to modulate thyroid cancer progression.

Wei Liu, S. Asa, S. Ezzat, 2007, Cancer research.

The melanoma-associated antigen A3 mediates fibronectin-controlled cancer progression and metastasis.

Wei Liu, S. Asa, S. Ezzat, 2008, Cancer research.

A prospective multicenter octreotide dose response study in the treatment of acromegaly

A. Harris, D. Redelmeier, S. Ezzat, 1995, Journal of endocrinological investigation.

A Systematic Review and Meta-Analysis of the Diagnostic Performance of BRAF V600E Immunohistochemistry in Thyroid Histopathology

S. Asa, S. Ezzat, L. Thabane, 2019, Endocrine Pathology.

Intrathyroidal Parathyroid Carcinoma: An Atypical Thyroid Lesion

S. Asa, S. Ezzat, R. Kim, 2018, Front. Endocrinol..

Molecular basis off hurthle cell papillary thyroid carcinoma.

C. Cheung, S. Asa, S. Ezzat, 2000, The Journal of clinical endocrinology and metabolism.

Prevalence of activating ras mutations in morphologically characterized thyroid nodules.

S. Asa, S. Ezzat, J. Freeman, 1996, Thyroid : official journal of the American Thyroid Association.

Molecular and Cellular Pathobiology FGFR 2 Isoforms Support Epithelial – Stromal Interactions in Thyroid Cancer Progression

W. Liu, S. Asa, S. Ezzat, 2012 .

Prolactin, a potential biomarker for chronic GVHD activity

S. Ezzat, J. Lipton, A. Viswabandya, 2020, European journal of haematology.

A Systematic Review and Meta-Analysis of Patient Preferences for Combination Thyroid Hormone Treatment for Hypothyroidism

S. Ezzat, L. Thabane, A. Sawka, 2019, Front. Endocrinol..

Clinical predictors of advanced sellar masses.

W. Kucharczyk, S. Ezzat, A. Sawka, 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Pregnancy in acromegaly: experience from two referral centers and systematic review of the literature

S. Ezzat, A. Colao, Sonia Cheng, 2012, Clinical endocrinology.

The Pangenomic Classification of Pituitary Neuroendocrine Tumors: Quality Histopathology is Required for Accurate Translational Research

S. Asa, S. Yamada, S. Ezzat, 2021, Endocrine Pathology.

Pituitary carcinoma: reclassification and implications in the NET schema

S. Asa, S. Ezzat, 2022, Endocrine oncology.

Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution

L. Reiniger, S. Asa, S. Yamada, 2019, Pituitary.

The Role of Mediators of Cell Invasiveness, Motility, and Migration in the Pathogenesis of Silent Corticotroph Adenomas

S. Asa, S. Ezzat, G. Zadeh, 2013, Endocrine Pathology.

Improved diagnostic accuracy of inferior petrosal sinus sampling over imaging for localizing pituitary pathology in patients with Cushing's disease.

D. Redelmeier, G. Booth, K. Kovacs, 1998, The Journal of clinical endocrinology and metabolism.

ED2: COST-EFFECTIVENESS OF ACROMEGALY TREATMENTS

S. Ezzat, L. Wilson, Jennifer Shin, 1999 .

AACE Medical Guidelines for Clinical Practice for the diagnosis and treatment of acromegaly.

S. Ezzat, M. Vance, D. Cook, 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Growth patterns of pituitary adenomas and histopathological correlates.

Walter Kucharczyk, Fred Gentili, Shereen Ezzat, 2014, The Journal of clinical endocrinology and metabolism.

Asynchronous pituitary adenomas with differing morphology.

K. Kovacs, S. Ezzat, É. Horváth, 1995, Archives of Pathology & Laboratory Medicine.

A randomized, controlled, multicentre trial comparing pegvisomant alone with combination therapy of pegvisomant and long‐acting octreotide in patients with acromegaly

S. Ezzat, C. Strasburger, G. Layton, 2009, Clinical endocrinology.

The Diagnosis of Neuroendocrine Neoplasms

S. Ezzat, A. Akirov, L. Amer, 2020 .

Recurrent acromegaly resulting from ectopic growth hormone gene expression by a metastatic pancreatic tumor

S. Ezzat, S. Melmed, S. Yamashita, 1993, Cancer.

Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas.

S. Asa, S. Ezzat, H. Smyth, 1995, The Journal of clinical endocrinology and metabolism.

Growth hormone‐releasing hormone (GHRH) and GHRH receptor (GHRH‐R) isoform expression in ectopic acromegaly

S. Asa, K. Kovacs, S. Ezzat, 2001, Clinical endocrinology.

Medical Management of Pituitary Adenomas: Structural and Ultrastructural Changes

S. Asa, S. Ezzat, 2004, Pituitary.

Continuous Versus Intermittent Subcutaneous Infusion of Octreotide in the Treatment of Acromegaly

A. Harris, S. Ezzat, S. Ezzat, 1995, Journal of clinical pharmacology.

Protocol for the examination of specimens from patients with primary pituitary tumors.

E. Laws, S. Asa, K. Kovacs, 2011, Archives of pathology & laboratory medicine.

Canadian consensus guidelines for the diagnosis and management of acromegaly.

S. Ezzat, E. Ur, C. Chik, 2006, Clinical and investigative medicine. Medecine clinique et experimentale.

Anabolic growth hormone action improves submaximal measures of physical performance in patients with HIV-associated wasting.

S. Ezzat, Scott Thomas, J. Esposito, 2005, American journal of physiology. Endocrinology and metabolism.

Complete anterior pituitary failure and postpartum cardiomyopathy.

S. Ezzat, A. Parikh, 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Managing newly diagnosed thyroid cancer

S. Ezzat, J. Brierley, D. Goldstein, 2014, Canadian Medical Association Journal.

The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes.

M. Laakso, K. Jablonski, J. Florez, 2013, Cell metabolism.

Women awaiting knee replacement have reduced function and growth hormone.

S. Ezzat, L. Woodhouse, Scott Thomas, 2003, Clinical orthopaedics and related research.

Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.

B. Chan, J. Waldron, B. O'Sullivan, 2018, International journal of radiation oncology, biology, physics.

Patients' experiences following local–regional recurrence of thyroid cancer: A qualitative study

S. Ezzat, R. Tsang, J. Brierley, 2013, Journal of surgical oncology.

The diagnosis and management of acromegaly: a Canadian consensus report.

S. Ezzat, E. Ur, O. Rorstad, 1996, Clinical and investigative medicine. Medecine clinique et experimentale.

The Cancer/Testis Antigen Melanoma-Associated Antigen-A3/A6 Is a Novel Target of Fibroblast Growth Factor Receptor 2-IIIb through Histone H3 Modifications in Thyroid Cancer

S. Asa, S. Ezzat, T. Kondo, 2007, Clinical Cancer Research.

The Cancer/Testis AntigenMelanoma-Associated Antigen-A3/A6 Is a NovelTarget of Fibroblast Growth Factor Receptor 2-IIIb through Histone H3Modifications in Thyroid Cancer

S. Asa, S. Ezzat, T. Kondo, 2007 .

Comparison of body composition assessment methods in patients with human immunodeficiency virus-associated wasting receiving growth hormone.

S. Ezzat, Scott Thomas, J. Esposito, 2006, The Journal of clinical endocrinology and metabolism.

Pancreatic Neuroendocrine Tumor Producing Insulin and Vasopressin

S. Asa, S. Ezzat, M. Krzyzanowska, 2018, Endocrine Pathology.

Measures of submaximal aerobic performance evaluate and predict functional response to growth hormone (GH) treatment in GH-deficient adults.

S. Asa, S. Ezzat, L. Woodhouse, 1999, The Journal of clinical endocrinology and metabolism.

Significance of Crooke's Hyaline Change in Nontumorous Corticotrophs of Patients With Cushing Disease

S. Asa, S. Ezzat, I. Shimon, 2021, Frontiers in Endocrinology.

FLCN-Driven Functional Adrenal Cortical Carcinoma with High Mitotic Tumor Grade: Extending the Endocrine Manifestations of Birt-Hogg-Dubé Syndrome

S. Ezzat, R. Kim, O. Mete, 2023, Endocrine Pathology.

Evaluation of the WHO 2010 Grading and AJCC/UICC Staging Systems in Prognostic Behavior of Intestinal Neuroendocrine Tumors

S. Asa, S. Ezzat, S. Serra, 2013, PloS one.

A Systematic Review and Meta-Analysis of Subsequent Malignant Neoplasm Risk After Radioactive Iodine Treatment of Thyroid Cancer.

C. Goldsmith, S. Ezzat, R. Tsang, 2018, Thyroid : official journal of the American Thyroid Association.

Pituitary Tumor AP-2α Recognizes a Cryptic Promoter in Intron 4 of Fibroblast Growth Factor Receptor 4*

R. Weigel, S. Asa, S. Ezzat, 2003, Journal of Biological Chemistry.

Ultrasound in active surveillance for low-risk papillary thyroid cancer: imaging considerations in case selection and disease surveillance

K. Higgins, R. Gilbert, S. Ezzat, 2021, Insights into Imaging.

A soluble dominant negative fibroblast growth factor receptor 4 isoform in human MCF-7 breast cancer cells.

S. Asa, S. Ezzat, L. Zheng, 2001, Biochemical and biophysical research communications.

Cognitive functioning in thyroid cancer survivors: a systematic review and meta-analysis

S. Ezzat, L. Bernstein, L. Thabane, 2019, Journal of Cancer Survivorship.

S. Ezzat, L. Thabane, L. Bresner, 2015, The Journal of clinical endocrinology and metabolism.

A minimally invasive approach to the management of bronchial carcinoid tumors associated with ectopic Cushing’s Syndrome

S. Ezzat, N. Ferguson, H. Smyth, 1998, Endocrine pathology.

The Breast Cancer Susceptibility Gene Product Fibroblast Growth Factor Receptor 2 Serves as a Scaffold for Regulation of NF-κB Signaling

Shereen Ezzat, Wei Liu, Sylvia L. Asa, 2012, Molecular and Cellular Biology.

A Prospective Mixed-Methods Study of Decision-Making on Surgery or Active Surveillance for Low-Risk Papillary Thyroid Cancer

K. Higgins, R. Gilbert, G. Tomlinson, 2020, Thyroid : official journal of the American Thyroid Association.

Spuriously Elevated Serum IGF-1 in Adult Individuals with Delayed Puberty: A Diagnostic Pitfall

S. Ezzat, S. Imran, P. Trainer, 2010, International journal of endocrinology.

Male occult triple-negative breast cancer with dermatomyositis: a case report and review of the literature

S. Ezzat, M. He, Le Zhang, 2017, OncoTargets and therapy.

Distinct transcriptional control and action of fibroblast growth factor receptor 4 in differentiating skeletal muscle cells

S. Asa, S. Ezzat, Shunjiang Yu, 2004, Laboratory Investigation.

Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel–Lindau disease

S. Asa, S. Ezzat, O. Mete, 2013, Virchows Archiv.

Microadenomatosis of the pancreas in von Hippel-Lindau disease.

S. Asa, S. Ezzat, R. Chetty, 2006, The American journal of surgical pathology.

CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases

S. Asa, S. Ezzat, A. Bamberger, 2007, Oncogene.

Sp1-Mediated Transcriptional Control of Fibroblast Growth Factor Receptor 4 in Sarcomas of Skeletal Muscle Lineage

M. Ladanyi, S. Asa, S. Ezzat, 2004, Clinical Cancer Research.

Comprehensive characterization of a Canadian cohort of von Hippel‐Lindau disease patients

S. Asa, S. Ezzat, G. Zadeh, 2019, Clinical genetics.

The Driver Role of Pathologists in Endocrine Oncology: What Clinicians Seek in Pathology Reports

S. Ezzat, W. D. de Herder, M. Volante, 2023, Endocrine pathology.

Growth Hormone Deficiency and Physical Function

S. Asa, S. Ezzat, L. Woodhouse, 2001 .

Exploring the relationship between patients’ information preference style and knowledge acquisition process in a computerized patient decision aid randomized controlled trial

Sharon E. Straus, Amiram Gafni, David Goldstein, 2015, BMC Medical Informatics and Decision Making.

Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow‐up from a decision‐aid randomized trial

A. Gafni, S. Straus, S. Ezzat, 2015, Cancer.

Thyroid cancer patients’ involvement in adjuvant radioactive iodine treatment decision-making and decision regret: an exploratory study

A. Gafni, S. Straus, S. Ezzat, 2011, Supportive Care in Cancer.

How can we meet the information needs of patients with early stage papillary thyroid cancer considering radioactive iodine remnant ablation?

A. Gafni, S. Ezzat, R. Tsang, 2011, Clinical endocrinology.

Regional differences in opinions on adjuvant radioactive iodine treatment of thyroid carcinoma within Canada and the United States.

A. Gafni, S. Straus, S. Ezzat, 2007, Thyroid : official journal of the American Thyroid Association.

Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting.

S. Arver, K. Yarasheski, S. Asa, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Thyroid Incidentalomas: Prevalence by Palpation and Ultrasonography

D. Sarti, G. Braunstein, S. Ezzat, 1994 .

Pituitary Disorders: Diagnosis and Management

Shereen Ezzat, Edward R. Laws, Sylvia L. Asa, 2013 .

Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior

S. Asa, S. Ezzat, S. Gallinger, 2013, Cancer medicine.

In vivo responsiveness of morphological variants of growth hormone-producing pituitary adenomas to octreotide.

A. Harris, D. Redelmeier, K. Kovacs, 1995, European journal of endocrinology.

Fibroblast growth factor receptor 4 (FGFR4) mediates signaling to the prolactin but not the FGFR4 promoter.

S. Asa, S. Ezzat, Shunjiang Yu, 2002, American journal of physiology. Endocrinology and metabolism.

Fibroblast growth factor receptor 4 ( FGFR 4 ) mediates signaling to the prolactin but not the FGFR 4 promoter

S. Asa, S. Ezzat, Lei Zheng, 2002 .

Effect of octreotide on glucose tolerance in acromegaly.

A. Harris, S. Ezzat, S. Ezzat, 1994, European journal of endocrinology.

Insulin-like growth factor binding protein-1 is elevated in patients with polycythemia vera and stimulates erythroid burst formation in vitro.

S. Ezzat, A. Mirza, A. Axelrad, 1997, Blood.

Endocrine applications of the somatostatin analogue octreotide (Sandostatin).

S. Ezzat, S. Melmed, S. Ezzat, 1992, Metabolism: clinical and experimental.

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer: update to study protocol with follow-up extension

A. Gafni, S. Straus, S. Ezzat, 2015 .

The PI3K/AKT/mTOR pathway in the pathophysiology and treatment of pituitary adenomas.

T. Tateno, S. Asa, S. Ezzat, 2014, Endocrine-related cancer.

Inhibition of the sodium potassium adenosine triphosphatase pump sensitizes cancer cells to anoikis and prevents distant tumor formation.

J. Wrana, S. Ezzat, A. Datti, 2009, Cancer research.

Gender-specific responses of lean body composition and non-gender-specific cardiac function improvement after GH replacement in GH-deficient adults.

S. Nussey, S. Ezzat, T. Mattioni, 2002, The Journal of clinical endocrinology and metabolism.

Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer - a randomized controlled trial

A. Gafni, S. Straus, S. Ezzat, 2010, Trials.

Myostatin and insulin-like growth factor-I and -II expression in the muscle of rats exposed to the microgravity environment of the NeuroLab space shuttle flight.

R. Tarnuzzer, S. Asa, S. Ezzat, 2000, The Journal of endocrinology.

Biomarkers of aggressive pituitary adenomas.

S. Asa, S. Ezzat, O. Mete, 2012, Journal of molecular endocrinology.

68Ga-DOTATATE PET/CT in the Initial Diagnosis of Patients With Clinical, Imaging, and/or Biochemical Suspicion of a Neuroendocrine Tumor

S. Ezzat, U. Metser, A. Singnurkar, 2023, Clinical nuclear medicine.

Diagnosis and management of hyperprolactinemia.

S. Ezzat, E. Ur, G. Wand, 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

The Breast Cancer Susceptibility Gene FGFR 2 Serves as a 3 Scaffold for Regulation of NF-κβ Signaling

Wei Liu, S. Asa, S. Ezzat, 2012 .

From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal.

S. Ezzat, M. Korbonits, H. Ikeda, 2017, Endocrine-related cancer.

FGF receptor signaling at the crossroads of endocrine homeostasis and tumorigenesis.

S. Asa, S. Ezzat, 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Endocrine tumors of the female reproductive tract

S. Ezzat, Sylvia L. Asa, 2023, Molecular and Cellular Endocrinology.

Acromegaly: Clinical and Biochemical Features in 500 Patients

A. Harris, D. Redelmeier, S. Ezzat, 1994 .